Inozyme Pharma
Stefan Riley is currently the Senior Director of Investor Relations and Corporate Communications at Inozyme Pharma. Prior to this role, Stefan held positions at Ten Bridge Communications and Evelo Biosciences in investor relations and communications. Stefan also has experience in operations management at Harvard University Graduate School of Design and Beth Israel Deaconess Medical Center. Stefan holds a Bachelor of Music degree from Illinois Wesleyan University.
This person is not in any teams
Inozyme Pharma
Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases.